Masimo Corp (MASI)
124.10
+3.49
(+2.89%)
USD |
NASDAQ |
May 17, 16:00
123.98
-0.12
(-0.10%)
After-Hours: 20:00
Masimo SG&A Expense (Quarterly): 159.90M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 159.90M |
December 31, 2023 | 159.90M |
September 30, 2023 | 156.10M |
June 30, 2023 | 151.70M |
March 31, 2023 | 196.30M |
December 31, 2022 | 185.80M |
September 30, 2022 | 174.60M |
June 30, 2022 | 188.30M |
March 31, 2022 | 108.90M |
December 31, 2021 | 104.20M |
September 30, 2021 | 100.60M |
June 30, 2021 | 93.90M |
March 31, 2021 | 96.70M |
December 31, 2020 | 90.29M |
September 30, 2020 | 90.38M |
June 30, 2020 | 98.46M |
March 31, 2020 | 89.88M |
December 31, 2019 | 81.94M |
September 30, 2019 | 80.35M |
June 30, 2019 | 78.16M |
March 31, 2019 | 74.20M |
December 31, 2018 | 73.21M |
September 30, 2018 | 71.54M |
June 30, 2018 | 70.45M |
March 31, 2018 | 70.22M |
Date | Value |
---|---|
December 31, 2017 | 74.55M |
September 30, 2017 | 65.70M |
June 30, 2017 | 66.67M |
March 31, 2017 | 66.09M |
December 31, 2016 | 70.46M |
September 30, 2016 | 57.84M |
June 30, 2016 | 63.89M |
March 31, 2016 | 62.51M |
December 31, 2015 | 70.65M |
September 30, 2015 | 59.61M |
June 30, 2015 | 61.67M |
March 31, 2015 | 60.80M |
December 31, 2014 | 61.48M |
September 30, 2014 | 62.06M |
June 30, 2014 | 61.35M |
March 31, 2014 | 56.12M |
December 31, 2013 | 55.93M |
September 30, 2013 | 53.09M |
June 30, 2013 | 54.17M |
March 31, 2013 | 52.27M |
December 31, 2012 | 51.57M |
September 30, 2012 | 48.26M |
June 30, 2012 | 47.65M |
March 31, 2012 | 46.47M |
December 31, 2011 | 43.93M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
78.16M
Minimum
Jun 2019
196.30M
Maximum
Mar 2023
124.32M
Average
102.40M
Median
SG&A Expense (Quarterly) Benchmarks
Boston Scientific Corp | 1.364B |
Integer Holdings Corp | 46.93M |
Stryker Corp | 1.84B |
Insulet Corp | 199.70M |
Shockwave Medical Inc | 103.72M |